Cloning

1. Meaning and types of cloning

A clone is a copy derived from a common biological source. Cloning occurs naturally through processes such as binary fission in bacteria and vegetative propagation in plants. Identical twins arise when an early embryo splits; they are naturally occurring genetic counterparts rather than products of laboratory nuclear transfer. Artificial cloning applies controlled techniques to reproduce selected DNA sequences, cells or whole organisms.

Molecular or gene cloning produces copies of a DNA fragment, usually by inserting it into a vector that replicates inside a host cell. Cell cloning establishes a population from a single ancestral cell. Organismal cloning produces an individual through methods such as embryo splitting or somatic cell nuclear transfer. These categories differ in their starting materials, procedures and objectives.

Plant tissue culture enables rapid multiplication of selected plants under sterile conditions. Many plant cells can regenerate an entire plant under suitable culture conditions, reflecting cellular totipotency. Micropropagation is widely used for crops such as banana and ornamentals such as orchids. However, tissue culture does not invariably produce genetically identical plants: somaclonal variation may arise during culture. Meristem culture can help obtain plants free from certain viruses, but disease freedom requires testing.

• Cloning is not synonymous with genetic engineering: a clone need not contain any deliberately altered DNA.
• Cloning and sexual reproduction differ because sexual reproduction normally combines nuclear genetic material from two parents.
• Genetic similarity does not guarantee identical appearance, behaviour, health or lifespan.

2. Molecular cloning and its applications

In conventional molecular cloning, a DNA fragment and a suitable vector are cut using compatible restriction enzymes, and DNA ligase joins them. The recombinant vector is introduced into a host, often Escherichia coli. A plasmid vector typically contains an origin of replication, a selectable marker and a region for inserting foreign DNA. Modern assembly methods can also join DNA without relying on the same restriction-and-ligation workflow.

Selection identifies cells carrying a vector, while additional screening determines whether the desired insert is present and correctly arranged. Growth of a selected host colony generates many copies of the inserted sequence. If protein production is intended, an expression vector must provide appropriate regulatory sequences, and the host must support the necessary processing of that protein.

Applications include gene-function studies, construction of DNA libraries, production of recombinant insulin and enzymes, and preparation of research reagents. Polymerase chain reaction also amplifies DNA, but it does so in vitro using primers and a DNA polymerase. Unlike conventional molecular cloning, PCR does not require a living host or a replicating vector. DNA amplification should therefore not automatically be described as organismal cloning.

• An origin of replication enables vector replication in a compatible host.
• A selectable marker helps distinguish transformed cells from cells lacking the vector.
• An expression vector supports gene expression; merely cloning a gene does not ensure that its protein will be produced.

3. Somatic cell nuclear transfer and genetic identity

Somatic cell nuclear transfer, or SCNT, starts with an unfertilised egg from which the nuclear material is removed. A nucleus from a somatic cell is transferred into this enucleated egg, or the donor cell is fused with it. Electrical or chemical stimulation activates development. Factors in the egg cytoplasm must reprogramme the differentiated nucleus so that it can support early embryonic development.

For reproductive cloning, a developing embryo is transferred into a suitable surrogate, with the intention of producing a live offspring. Dolly was produced at the Roslin Institute using a nucleus from an adult mammary-gland cell. Her birth demonstrated that the nuclear genome of a differentiated adult cell could, under suitable conditions, support the development of an entire mammal.

An SCNT clone is not a perfect copy in every biological respect. Its nuclear genome principally matches the nucleus donor, whereas mitochondrial DNA generally comes from the egg donor; limited donor-cell mitochondrial carry-over may also occur. New mutations, epigenetic differences, uterine conditions, nutrition and later experience can further distinguish the clone. The surrogate provides the gestational environment but does not ordinarily supply the clone’s inherited DNA.

• SCNT does not require fertilisation by sperm.
• Embryo splitting separates cells or portions of an early embryo; it does not transfer an adult somatic nucleus.
• Reprogramming changes gene activity and epigenetic states rather than deliberately rewriting the entire DNA sequence.

4. Therapeutic cloning, stem cells and alternatives

Therapeutic cloning uses nuclear transfer to create an early embryo from which embryonic stem-cell lines may be derived, rather than seeking a live birth. The intended applications include disease modelling, drug testing and development of replacement tissues. Embryonic stem cells are pluripotent: they can form the major cell types of the body, but are not equivalent to a complete embryo capable of independently developing into an organism.

Because the cells’ nuclear genome can match a patient’s, therapeutic cloning may reduce some immune-compatibility problems. It does not guarantee complete freedom from rejection, and practical barriers include egg procurement, low efficiency, genetic stability, tumour risk and reliable differentiation into functional tissues. Deriving embryonic stem-cell lines generally involves destruction of the embryo, creating ethical concerns.

Induced pluripotent stem cells, or iPSCs, are generated by reprogramming somatic cells using defined factors, without an enucleated egg or creation of an SCNT embryo. They provide an important alternative for many research purposes, although safety and quality-control challenges remain. Neither iPSC generation nor therapeutic cloning should be confused with an established cure for every degenerative disease.

• Reproductive and therapeutic cloning can share an initial technique but differ in purpose and subsequent use.
• Pluripotency means broad differentiation potential, not the ability of a single stem cell to form an entire organism.
• A proposed stem-cell intervention requires evidence of safety and efficacy; the label ‘patient-specific’ is not sufficient.

5. Applications, limitations and Indian governance

Livestock cloning can multiply animals with valuable traits and support research on breeding and development. When combined with genetic modification, it can help establish animals carrying a desired alteration. However, cloning itself does not create a new beneficial allele or guarantee that a high-yielding donor’s performance will be reproduced under different environmental conditions.

Conservation programmes may clone individuals from preserved cells to recover genetic material poorly represented in a surviving population. This can complement, but cannot replace, habitat protection, viable breeding populations and management of genetic diversity. Cloning extinct species is especially constrained by the absence of intact usable nuclei, suitable eggs and compatible surrogates. An ancient DNA sequence alone is not equivalent to a living cell suitable for SCNT.

Major limitations include low live-birth efficiency, pregnancy loss, placental abnormalities and health problems in some offspring. Incomplete epigenetic reprogramming is an important contributor. Animal welfare, the burden on egg donors and surrogates, high costs and excessive reliance on a narrow genetic base must therefore be evaluated alongside possible benefits.

In India, the ICMR–DBT National Guidelines for Stem Cell Research, 2017 place human reproductive cloning in the prohibited category. Relevant embryo-related stem-cell research falls under specialised oversight, with restrictions including the 14-day or primitive-streak limit, whichever occurs earlier, for in vitro embryo culture. These guidelines should not be presented as a standalone parliamentary cloning statute. Approval requirements depend on the activity; clinical research, animal experimentation and work involving genetically engineered organisms may additionally engage their respective regulatory frameworks.

• For genetically engineered organisms, the Rules, 1989 under the Environment (Protection) Act, 1986 are relevant; cloning alone does not necessarily imply genetic engineering.
• Ethical assessment should distinguish established laboratory applications from experimental reproductive or clinical claims.

Previous year questions

No source-linked PYQ is available here yet. Use the practice questions below.

Practice questions